Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method

Tenofovir alafenamide (TAF) is a novel prodrug of tenofovir (TFV) that has been approved for the treatment of chronic hepatitis B virus (HBV) infection. It has greater plasma stability and more favorable renal safety than tenofovir disoproxil fumarate (TDF), the first approved oral prodrug of TFV. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Na, Zhou, Guanlun, Cheng, Xiaoliang, He, Jun, Chen, Yan, Chen, Chao, Li, Meijuan, Ge, Jiajia, Wang, Min, Zhang, Tianqi, Ge, Weihong, Zhu, Huaijun, Han, Guorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414412/
https://www.ncbi.nlm.nih.gov/pubmed/34483946
http://dx.doi.org/10.3389/fphar.2021.734760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414412/
https://www.ncbi.nlm.nih.gov/pubmed/34483946
http://dx.doi.org/10.3389/fphar.2021.734760

Ejemplares similares